Indaptus Therapeutics Inc. (INDP)
NASDAQ: INDPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 7, 3:19 PM ET
INDP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $306.46M
- EPS (TTM)
- -$6.15
- Dividend yield
- None
- 52-week range
- 0.92 – 5.96
- Day range
- 2.23 – 2.57
- Volume / Avg
- 560.43K / 822.38K
- Beta
- —
- Shares outstanding
- 133.24M
52-week range
INDP stock today
Indaptus Therapeutics (INDP) is trading at $2.30 on Oct 7, down 11.20% (-$0.29), versus the S&P 500's 0.25% decline. Shares are 61.4% below their 52-week high of $5.96 and 150.0% above the 52-week low of $0.92, in the middle of the past year's range. Indaptus Therapeutics has posted a net loss over the last twelve months (EPS of -$6.15), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Indaptus Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Indaptus Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RLMDRelmada Therapeutics Inc. | 3.25 | -1.07% | $346.14M | vs INDP |
| ENTAEnanta Pharmaceuticals Inc. | 12.37 | +1.60% | $360.14M | vs INDP |
| CYPHCypherpunk Technologies Inc. | 3.06 | -6.30% | $329.22M | vs INDP |
| ARCTArcturus Therapeutics Holdings Inc. | 12.79 | -1.62% | $363.53M | vs INDP |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.86% | $364.57M | vs INDP |
| EBSEmergent BioSolutions Inc. | 7.18 | +3.31% | $368.14M | vs INDP |
| TTRXTurn Therapeutics Inc. | 12.21 | +4.90% | $370.79M | vs INDP |
| IRDOpus Genetics Inc. | 4.49 | +2.40% | $373.13M | vs INDP |
Indexes, lists and sector
Largest Health Care stocks
Indaptus Therapeutics stock FAQ
What is Indaptus Therapeutics's stock price today?
INDP last traded at $2.30 as of Oct 7, 3:19 PM EDT, down 11.20% on the day. Prices are delayed at least 15 minutes.
What is the INDP 52-week high?
The 52-week high for INDP is $5.96 and the 52-week low is $0.92. The stock is currently 61.4% below its high.